Hamlet BioPharma invites to investor meeting on the 23rd of April

Hamlet Biopharma
|
April 22, 2025

As previously announced Hamlet BioPharma invites you to our monthly investors’ meeting to
be held on the 23rd of April 2025, at 12:00.

Please click on the link below to participate in the meeting

https://us06web.zoom.us/j/85453862213?pwd=laaLkdTnsGdnUBu9FEgegUOBgQLr0g.1

 

We would also like to draw your attention to our new teaser that summarises the company’s position.

To view the teaser, please click on the link below.

https://hamletbiopharma.com/wp-content/uploads/2025/04/Hamlet-Corporate-Teaser- version_8.pdf

 

 

For more information, please contact

Jakob Testad, CFO, Hamlet BioPharma AB, +46 708 48 42 10,
jakob.testad@hamletbiopharma.com

Catharina Svanborg, CEO and founder, +46 709 42 65 49
catharina.svanborg@hamletpharma.com

An innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections.
Hamlet BioPharma AB
Klinikgatan 32
SE-222 42 Lund
info@hamletbiopharma.com
Org. no. 556568-8958
Subscribe to receive
Pressreleases and Newsletters
© 2026
Hamlet BioPharma.